Two distinct mechanisms are described, which includehypercalcemia by local osteolytic lesions (bone metastasis) and humoralhypercalcemia by the activation of RANK-RANKL (receptor activator of nuclearfactor κB and its ligand). This evidence concerns the gene TNFRSF11A and bone metastasis.